Bronchial smooth muscle cells play a central role in normal lung physiology by controlling airway tone. In addition, airway smooth muscle hyperplasia and hypertrophy are important factors in the pathophysiology of asthma. In this study, expression of ␤ ig-h3, a recently identified component of the extracellular matrix (ECM), was investigated in primary human bronchial smooth muscle (HBSM) cells. Northern blot analysis demonstrated that treatment of cultured HBSM cells with transforming growth factor-␤ 1 resulted in a 4-to 5-fold increase in the steady-state level of ␤ ig-h3 messenger RNA. Western blot analysis of secreted proteins using monospecific antibodies generated against peptide sequences found in the N-and C-terminal regions of the protein identified several isoforms having apparent mass of 70-74 kD. Immunohistochemical analysis of human lung localized ␤ ig-h3 to the vascular and airway ECM, and particularly to the septal tips of alveolar ducts and alveoli, suggesting that it may have a morphogenetic role. Analysis of cultured HBSM cells identified ␤ ig-h3 in both the ECM as well as the cytoplasm, and surprisingly also in the nucleus. These results demonstrate that ␤ ig-h3 is produced by resident lung cells, is a component of lung ECM, and may play an important role in lung structure and function. The presence of this protein in nuclei suggests that it may have regulatory functions in addition to its role as a structural component of lung ECM. Lung development and function are dependent on the proper interaction of resident cells with each other and with specific extracellular matrix (ECM) components (1-4). In the bronchus, smooth muscle cells reside in a network of fibrous connective tissue below the respiratory epithelium and play a key role in regulating airway tone. Further, increased proliferation and other alterations in these cells have been implicated in the pathophysiology of asthma (5-8). To better understand smooth muscle cell physiology and its role in specific pathologic conditions, it is necessary to define the ECM components produced by these cells, establish their anatomic distribution, and determine the interaction of smooth muscle and other resident lung cells with these proteins. The goal of the current study was to examine the expression and deposition of ␤ ig-h3, a newly described ECM protein, by bronchial smooth muscle cells.
Lung development and function are dependent on the proper interaction of resident cells with each other and with specific extracellular matrix (ECM) components (1) (2) (3) (4) . In the bronchus, smooth muscle cells reside in a network of fibrous connective tissue below the respiratory epithelium and play a key role in regulating airway tone. Further, increased proliferation and other alterations in these cells have been implicated in the pathophysiology of asthma (5) (6) (7) (8) . To better understand smooth muscle cell physiology and its role in specific pathologic conditions, it is necessary to define the ECM components produced by these cells, establish their anatomic distribution, and determine the interaction of smooth muscle and other resident lung cells with these proteins. The goal of the current study was to examine the expression and deposition of ␤ ig-h3, a newly described ECM protein, by bronchial smooth muscle cells.
The ECM is composed of a wide array of macromolecules, including collagens, laminins, elastin, and proteoglycans (reviewed in 9). The components of the ECM interact with each other to form a highly organized framework that provides a support structure for resident stromal and parenchymal cells, and maintains tissue architecture. The interaction of resident cells with the ECM is crucial for normal development and changes in these interactions likely play important roles in many pathologic conditions. Whereas the major components of the ECM have been identified and extensively characterized, considerably less is known about factors that interconnect these components with one another and resident cells in different tissues.
␤ ig-h3 was first observed in reductive saline extracts of fetal bovine nuchal ligament as a protein that migrated with an apparent molecular weight of ‫ف‬ 70 kD (10) . The protein was subsequently cloned by differential screening of a complementary DNA (cDNA) library prepared from A549 human lung cells treated with transforming growth factor-beta 1 (TGF-␤ 1) (11) . Recently, highly homologous cDNAs encoding mouse, chick, pig, and rabbit ␤ ig-h3 have been cloned (12) (13) (14) (15) . Other proteins having more limited homology to ␤ ig-h3 include periostin (16) , Drosophila fasciclin I (17) , and several bacterial proteins (18) . The nascent protein contains a secretory signal sequence and is composed largely of four homologous internal domains, the last one of which contains an arginine-glycine-aspartic acid sequence that may act as a cell attachment/integrin binding site (11, 12) . Whereas the physiologic function of ␤ ig-h3 has not been elucidated, the porcine protein has been shown to bind collagens I, II, and IV (13) , and ␤ ig-h3 has been hypothesized to serve a linking function, interconnecting different matrix components with each other and resident cells (12, 13, 19, 20) .
Northern blot analysis demonstrated that ␤ ig-h3 was expressed in a variety of human and mouse tissues with the highest concentrations found in uterine tissue, and readily detectable messenger RNA (mRNA) levels were found in heart, breast, prostate, skeletal muscle, testes, thyroid, kidney, liver, and stomach tissues (12) . Expression was absent in brain, spleen, and parathyroid tissues. At the protein level, the distribution of ␤ ig-h3 has been examined in fetal bovine tissues (19) . This analysis showed that ␤ ig-h3 was associated with collagen fibers in developing nuchal ligament, aorta, lung, and mature cornea. Immunoreactive material was also present in reticular fibers in fetal spleen as well as capsule and tubule basement membranes in developing kidney. From this study, it was concluded that the staining pattern closely resembled that of type VI collagen microfibrils.
Interestingly, missense mutations in this protein at positions 124 (Arg 124 → Cys or His) and 555 (Arg 555 → Gln or Trp) have been identified as causative mutations in hereditary corneal dystrophies (21) . Mutations at these sites are thought to cause the protein to denature, forming "amyloidogenic intermediates" that subsequently precipitate in the cornea (22) . This condition results in a progressive loss of vision, which can ultimately lead to blindness. These findings suggest that ␤ ig-h3 is important in eye physiology and that specific changes in protein primary sequence alter its functional role in the corneal ECM. However, no abnormal findings relative to the lung have been reported in patients with corneal dystrophies.
Whereas ␤ ig-h3 has been shown to be present in bovine tissues (19) and human cornea (22) , very little information is available regarding the distribution of the protein in other human tissues. The goal of the present study was to assess ␤ ig-h3 expression in the lung with emphasis on airway smooth muscle cells. We show that ␤ ig-h3 is present extensively in lung tissue, localizing to alveoli, alveolar ducts, and bronchioles in close juxtaposition to bronchial smooth muscle. Cultured bronchial smooth muscle cells produce readily detectable amounts of ␤ ig-h3 that is deposited in the ECM, and that surprisingly is also found in the nuclei of these cells.
Materials and Methods

Chemicals and Reagents
Goat-antirabbit-horseradish peroxidase (HRP) and goatantirabbit-rhodamine isothiocyanate conjugates were purchased from Sigma (St. Louis, MO). Recombinant human TGF-␤ 1 was generously supplied by Genentech (San Francisco, CA). Gradient polyacrylamide minigels were purchased from Novex (San Diego, CA).
Cell Culture
The human bronchial smooth muscle (HBSM) cell strains used in this study were derived from two healthy male donors, 37 and 16 yr of age (Clonetics, San Diego, CA). No significant differences were observed between the two cell strains with respect to their ␤ ig-h3 production. The cells were grown in Smooth Muscle Basal Medium supplemented with 5% fetal bovine serum (FBS), insulin (5 g/ml), human recombinant epidermal growth factor (10 ng/ml), human recombinant fibroblast growth factor (2 ng/ml), gentamicin (50 g/ml), and amphotericin-b (50 ng/ml) at 37 Њ C, 5% CO 2 . A549 human lung carcinoma cells were grown in RPMI 1640 containing 5% FBS. 8] , and 1 mM DTT) and layered over a 2-M sucrose cushion. The nuclei were pelleted by centrifugation (30,000 ϫ g , 45 min, at 4 Њ C) and resuspended in glycerol storage buffer (40% glycerol, 5 mM MgCl 2 , and 0.1 mM EDTA). For analysis, freshly purified nuclei were spread on glass slides, fixed for 10 min with phosphate-buffered saline (PBS) containing 1.5% formalin, and subsequently incubated with anti-␤ ig-h3 antibodies ( see subsequent section ), or propidium iodide, which specifically stains DNA.
Purification of Nuclei
Marker Enzymes
Cytochrome C reductase activity (endoplasmic reticulum/ microsomal marker enzyme) was determined in 25 mM Tris (pH 7.5), 300 mM CaCl, containing 50 M 2,6-dichloroindophenol, and 50 M nicotinamide adenine dinucleotide phosphate (NADPH) (23) . The oxidation of NADPH was monitored at 340 nm (E 340 ϭ 6.22 mM Ϫ 1 ϫ cm Ϫ 1 [24] ). Galactosyltransferase activity (Golgi marker enzyme) was determined using the modified procedure of RensDomiano and Roth (25) . Briefly, reactions contained extract (20-50 g protein) in 25 mM N -2-hydroxyethylpiperazine-N Ј -ethane sulfonic acid (Hepes) (pH 7.0), 1 mM DTT, 0.5% Triton X-100, 40 mM MnCl 2 , 2 mM adenosine triphosphate, 20 mM N-acetylglucosamine, and 2 mM uridine diphosphate-[ 
Production and Affinity Purification of Antibodies and Western Blot Analysis
Three synthetic peptides IGTNRKYFTNCKQWYQRKIC (residues 55-74, antibody [Ab] 1186), TQLYTDRTEKL-RPEMEG-C (residues 118-134 of human ␤ ig-h3, Ab 1073), and ALPPRERSRLL-C (residues 549-559, Ab 1077) were synthesized and purified by high pressure liquid chromatography by BioSynthesis (Lewisville, TX). The second and third peptides were synthesized with an additional cysteine residue at the carboxy terminus to facilitate their coupling to maleimide activated keyhole limpet hemocyanin (KLH) (Pierce, Rockford, IL) at a substitution ratio of 1 mg peptide/mg KLH. Antibodies were prepared in rabbits by Cocalico Biologicals (Reamstown, PA) using the following immunization schedule: an initial injection of 250 g, followed 3 wk later by three biweekly injections of 100 g. For affinity purification of antibodies, individual peptides were immobilized on Sulfolink coupling gel (Pierce). The immunoglobulin G fraction of the antiserum was passed over the column, which was washed with PBS ( ‫ف‬ 10 column vol; 50 ml) until protein free. Bound antibodies were eluted with 100 mM glycine (pH 2.5), immediately neutralized with Tris base, and diluted to a concentration of 0.4 mg/ml before storage at Ϫ 70 Њ C (26).
Proteins were resolved on 8 to 16% polyacrylamide gradient gels under reducing conditions and transferred to nitrocellulose membranes. After transfer, the membranes were blocked in PBS containing 0.1% Tween 20 (PBST) containing 5% nonfat dry milk and subsequently incubated with anti-␤ ig-h3 antibodies diluted 1:1,000 in PBST and 0.1% bovine serum albumin (BSA). Bound antibody was detected with goat-antirabbit-HRP conjugate, using chloronaphthol as substrate.
Immunohistochemistry
Human lung tissue was fixed in 1% paraformaldehyde for 2 to 3 h at room temperature, followed by 0.5 M sucrose infusion, and embedded in OCT imbedding medium (Miles, Elkhart, IN) freezing compound. Frozen sections were cut and placed on glass slides. The tissue was treated with 6 M guanidine-HCl and 100 mM iodoacetamide followed by treatment with H 2 O 2 to reduce endogenous peroxidase activity (10). The tissue was incubated with primary antibody overnight, washed and incubated with biotinylated antirabbit IgG followed by streptavidin/HRP conjugate (Amersham, Piscataway, NJ), and developed with diaminobenzidine (Sigma) as substrate.
Cells (2 ϫ 10 5 ) were seeded in sterile eight well Lab Tek chamber slides (Nunc, Naperville, IL) and grown to confluence. The cells were washed twice with PBS, fixed with PBS containing 1.5% formalin for 10 min at 20 Њ C, washed with PBS, and permeabilized with PBS containing 0.1% Triton X-100 and 1% BSA. Next, cells were incubated with primary antibody (diluted 1:400 in PBST, 1% BSA) at 4 Њ C overnight, washed three times with PBST, and subsequently incubated with a rhodamine-conjugated goat-antirabbit IgG (diluted 1:500 in PBST, 0.1% BSA) for 1 h at 20 Њ C. The slides were washed, coverslipped, and examined with a Zeiss fluorescent microscope (Carl Zeiss, Inc., Thronwood, NY) equipped with epifluorescence optics. Control slides were treated in an identical manner, but with the addition of 10 g/ml peptide to block the primary antibody.
Northern Blots
Total cytoplasmic RNA was extracted with guanidinium thiocyanate/phenol chloroform extraction as described previously (27) . RNA was size fractionated on 1% agarose-formaldehyde gels, transferred to a Zeta-Probe membrane (Bio-Rad, Hercules, CA), and hybridized with a 2.1-kb ␤ ig-h3 cDNA labeled with [
32 P] using a Ready-To-Go DNA labeling kit (Pharmacia Biotech, Piscataway, NJ). RNA loading and transfer were evaluated by probing with a 1.4-kb glyceraldehyde phosphate dehydrogenase cDNA probe (28) . Equivalent loading and transfer were also verified by quantitative image analysis of ethidium bromide staining of ribosomal RNA in the blots themselves. The phosphorimages of the filters were digitized (Storm 840; Molecular Dynamics, Sunnyvale, CA) and the signal levels were quantified (Image-Quant V5.1 software; Molecular Dynamics) to determine the relative amounts of mRNA.
Results
Immunohistochemical Localization of ␤ ig-h3 in Human Lung
To determine the anatomic distribution of ␤ ig-h3 in human lung, tissue from a 2-yr-old child who had suffered an accidental death was embedded in OCT medium, and frozen sections were cut and incubated with Ab 1077. In formaldehyde-fixed tissue, staining with ␤ ig-h3 was negative, suggesting as in previous studies (19) , that the antibody binding sites may be masked. The fixed tissue sections were treated with guanidine-HCl followed by iodoacetamide to unmask reactive epitopes. Whereas the tissue morphology exhibited less than optimal cellular structures because of the powerful chaotropic activity, the treatment resulted in positive staining with Ab 1077. In the tissue, we observed staining of the ECM of the vasculature (not shown), alveolar ducts, as well as developing and formed alveolar walls ( Figures 1A and 1B) . Of particular interest was the intense staining localized to the septal tips of alveolar ducts and developing alveoli. Further, there was prominent staining of the matrix and associated smooth muscle in bronchioles ( Figure 1B) . Hence, ␤ ig-h3 is a component of pulmonary ECM where it is present in close approximation to resident smooth muscle cells and fibroblasts. These results provide strong evidence that the observations made with HBSM cells in culture ( see subsequent section ) are an accurate reflection of the behavior of these cells in vivo .
Expression of ␤ ig-h3 by Cultured HBSM Cells
Expression of ␤ ig-h3 was assessed in cultured HBSM cells. Our initial experiments compared ␤ ig-h3 mRNA expression by HBSM cells to that of A549 cells, the epithelial carcinoma cell line from which ␤ ig-h3 was originally cloned (11) . Northern blot analysis demonstrated that whereas both cell types expressed ␤ ig-h3, constitutive expression by HBSM cells was about 8-fold higher than that of A549 cells and comparable to A549 expression after treatment with TGF-␤ (Figure 2) . Treatment of HBSM cells with 1 ng/ml TGF-␤1 (shown to be an optimal concentration in preliminary experiments) for 48 h resulted in a 4-to 5-fold induction of ␤ig-h3 RNA (Figure 3 ). These results demonstrate that HBSM cells constitutively express ␤ig-h3 at a relatively high level, but that exposure of these cells to TGF-␤1 still results in a significant increased mRNA level.
We next investigated ␤ig-h3 expression at the protein level. For these studies, monospecific, affinity-purified antibodies were prepared against the N-terminal (Ab 1186 and Ab 1073; residues 55-74 and 118-134, respectively) and C-terminal (Ab 1077; residues 549-559) regions of the protein. Western blot analysis of proteins secreted into the conditioned medium, as well as proteins extracted from the matrix formed by the cultured cells, demonstrated that all antibodies reacted specifically with a 70 kD protein (Figure 4 ; only the results with Ab 1077 are shown). Interestingly, whereas several isoforms were identified in the medium, as has been noted by others (12, 19) , the protein Western blot analysis of medium and ECM proteins. HBSM cells were grown to confluence and removed from the dishes with PBS and 10 mM EDTA. The remaining matrix was solubilized with 1% sodium dodecyl sulfate and analyzed on Western blots under reducing conditions. Protein was detected using Ab 1077. Numbers on right indicate relative molecular mass in kD. Note the presence of multiple isoforms of ␤ig-h3 in conditioned medium, whereas a much more restricted pattern is found in the matrix. Identical results were obtained with Ab 1073.
extracted from the matrix appeared to contain only the largest isoform.
Immunohistochemical Localization of ␤ig-h3 in Cultures of HBSM Cells
The results described previously established that HBSM cells express ␤ig-h3. Our next objective was to assess ␤ig-h3 protein deposition in situ. Close and careful examination of the immunohistochemically stained tissue sections at high magnification suggested that the antibody may have been localized to the nuclei of some cells. However, this conclusion was quite tentative because of the distortion of the tissue caused by the treatment required to elicit reactivity. To evaluate ␤ig-h3 expression, cells were grown in eight-well slide chambers, fixed, and subsequently incubated with ␤ig-h3 antibodies. In HSBM cultures treated with Ab 1077 (prepared against the C-terminal region of the protein), fine strands of ECM stained positively (Figures 5A and 5B). In addition, fine punctate cytoplasmic staining partially surrounding the nucleus and possibly associated with the golgi and/or rough endoplasmic reticulum was detected ( Figure 5B) . In some cells, we observed very fine punctate staining of the nuclei ( Figure 5A) .
A markedly different staining pattern was detected when cells were incubated with Ab 1073 (prepared against the NH 2 -terminal region). Under these conditions, the nuclear region exhibited intense positive staining ( Figure 6 ). This staining pattern was judged to be intranuclear rather than on the cell surface by focusing above and below the plane of the cell monolayer. Very fine, faint staining of the ECM was also observed with this antibody upon overexposure of the fluorescent image ( Figure 6B ). We also observed nuclear staining when cells were incubated with Ab 1186 (Figure 7) , which recognizes an epitope in the N-terminal region of ␤ig-h3. For controls, HBSM cells were treated with (1) preimmune serum, (2) Ab 1073, 1077, or 1186, that were preincubated with immunizing peptide (Figures 5C, 6C , and 7A), or (3) secondary antibody alone. Under these conditions, immunostaining of cells and tissue was consistently negative.
Identification of ␤ig-h3 in the Nucleus of HBSM Cells
Although it is clear that ␤ig-h3 is secreted and becomes deposited in the ECM (Figures 1 and 5) , the results obtained when cells were stained with Ab 1073 and Ab 1186 (Figures 6 and 7 ) supported the observation with whole lung sections that ␤ig-h3 is also present in the nucleus of some cells. To confirm this finding, nuclei were purified from HBSM cells and examined by immunofluorescence microscopy. The homogeneity of the nuclear preparations was established by staining with propidium iodide, which specifically stains DNA (Figure 8) , and found to be pure at this level of resolution. Furthermore, assessment of subcellular marker enzyme activities (Table 1) demonstrated that the nuclear preparations were relatively free of contamination by golgi and endoplasmic reticulum and comparable in terms of purity to that obtained by others (29, 30) . Incubation of nuclei with Ab 1073 resulted in intense staining characterized by a stippled, punctate pattern. In addition, proteins extracted from the nuclei were subjected to Western blot analysis, which demonstrated that both Ab 1073 and Ab 1077 recognized several isoforms of ␤ig-h3 (Figure 8 ). These results unequivocally confirm the presence of this protein in HBSM cell nuclei.
Discussion
In this investigation, we found that HBSM cells constitutively express ␤ig-h3 mRNA, and the level of expression by these cells was considerably higher ‫ف(‬ 8-fold) than that of A549 cells (Figure 2) . Nevertheless, TGF-␤1 still significantly increased expression by the HBSM cells (Figure 3) . In contrast, we have observed that exposure of HBSM cells to the proinflammatory cytokine, interleukin 1␤, which upregulates a number of proinflammatory genes (31), had no effect on ␤ig-h3 expression levels (data not shown).
Results from several laboratories have demonstrated that ␤ig-h3 is a component of the ECM in vivo. Immunohistochemical analysis of bovine tissue previously localized the protein to the matrix in several tissues, including nuchal ligament, kidney, lung, and eye (19) . The protein has also been localized to the matrix in human cornea (22) and was isolated from a fiber-rich fraction of porcine cartilage (13) . In our study, we used immunofluorescent and Western blot analyses to demonstrate that ␤ig-h3 was present in matrix produced by HBSM cells. One predominant form with an apparent approximate mass of 70 kD was detected in the matrix, whereas several reactive isoforms, mainly of slightly lower molecular mass, were detected in the conditioned medium (Figure 4 ). This suggests that the larger isoform is preferentially incorporated into the matrix. We have obtained similar results with primary human lung fibroblast (GM05389) cells (data not shown). In lung tissue, ␤ig-h3 localized to matrix in the alveolar ducts and alveoli as well as in the bronchioles in close association with smooth muscle. Therefore, these results confirm that the protein is a compo- nent of lung matrix and suggest that bronchial smooth muscle cells are one source of ␤ig-h3 in vivo.
Because ␤ig-h3 is secreted and present in ECM, its localization to the nucleus was unexpected. However, the evidence supporting this conclusion is strong. Ab 1073 and 1186 consistently stained HBSM cell nuclei (Figures 6 and  7) as well as nuclei in other cell types, including human lung fibroblasts (data not shown). A similar immunostaining pattern was obtained with purified nuclei. Ab 1077 produced a weaker but still positive nuclear staining. In addition, both the N-terminal (1073) and C-terminal (1077) antibodies reacted with the same nuclear proteins on Western blots, indicating that both regions of the protein are present in the nuclear and secreted forms of the protein.
These results indicate that the epitope recognized by Ab 1073 (which stains nuclei) is accessible in nuclei, but not in matrix, whereas the epitope recognized by Ab 1077 (primarily staining matrix) is accessible in matrix, but only poorly accessible in nuclei. This could reflect the fact that ␤ig-h3 interacts with different ligands, which specifically bind these sites in these two compartments, thus blocking antibody binding. Alternatively, the protein may assume different conformations in these two compartments, altering epitope accessibility and/or antibody recognition.
The presence of this protein in ECM and nuclei raises several questions regarding protein trafficking. Because ␤ig-h3 contains a signal sequence on the amino terminus (residues 1-23; see Reference 11), it is predicted that the protein is targeted for secretion. Indeed, we have detected immunoreactive material in what appears to be golgi of HBSM and lung fibroblast cells, consistent with the translocation of this protein to the extracellular space (32, 33) . One possibility to explain nuclear localization is that the protein is secreted and subsequently taken up by cells, perhaps by receptor-mediated endocytosis. Alternatively, the protein may have multiple isoforms arising from alternative splicing in the 5Ј region of the mRNA or by post-translational proteolytic processing. These different ␤ig-h3 isoforms could potentially be targeted to specific compartments; some isoforms are secreted and deposited in the ECM, while other isoforms that lack the signal peptide are translocated to the nucleus. We are currently investigating these possibilities.
␤ig-h3 has been shown to enhance attachment and spreading of dermal fibroblasts, suggesting that it functions as an extracellular attachment protein in skin (20) . Indeed, the protein contains an RGD cell attachment/integrin recognition site in its C-terminal region. Immunofluorescence analysis of bovine tissue showed ␤ig-h3 associated with collagen fibers (19) . In addition, the porcine-derived ␤ig-h3 homologue has been reported to bind types I, II, and IV collagen (13) . These data suggest that ␤ig-h3 may act as a linker protein interconnecting specific matrix components, such as collagens, with each other and resident cells. For example, bronchial smooth muscle, or other resident lung cells, could use surface integrins to bind ␤ig-h3, which in turn, could bind collagen molecules present in the tissue stroma of the lung. The molecule would then serve a bridging function, connecting lung smooth muscle, or other resident cells, with matrix collagens or other ECM compartments. If this is the case, then we speculate that ␤ig-h3 plays an important role in the interaction of lung resident cells with the ECM and maintenance of lung structure.
It is generally believed that the interactions of lung epithelial, fibroblast, and smooth muscle cells with the ECM play a critical role in lung development and function. The localization of ␤ig-h3 to the forming alveolar walls, especially at the tips of newly forming septa, is of particular interest because elastin is also found at these sites. The localization of a condensed elastic matrix at the apex of forming alveolar septae suggested that this matrix might have a critical role in alveolar morphogenesis as opposed to a purely structural one (34) (35) (36) .
Alterations in cell/matrix interactions are involved in the pathogenesis of diseases such as asthma and fibrosis (5) (6) (7) (8) (9) . In lung fibrosis, matrix accumulation by lung fibroblasts, and possibly other cells, proceeds unabated. In this process, TGF-␤1 has been proposed to act as a master switch, controlling collagen accumulation (37) . In this environment, ␤ig-h3 could lead to increased noncovalent "crosslinking" of collagen molecules and other matrix components and also result in altered cell/matrix interactions. Consequently, changes in matrix composition, such as increased collagen/␤ig-h3 deposition in lung alveoli and bronchioles, could potentiate the fibrotic process by diminishing lung elasticity and function. Our results demonstrate that ␤ig-h3 is expressed by bronchial smooth muscle cells and once secreted, some of the protein becomes deposited in the ECM. In addition, this protein is present in nuclei, indicating that it may have other, as yet, unknown functions in addition to its role as a structural ECM component and potential cell attachment factor.
